<prompt> EMACO regimen of chemotherapy is used in the treatment ofCarcinoma cervixGestational trophoblastic neoplasiaMalignant Ovarian germ cell tumorEndometrial carcinoma  <response>: EMA-CO a cyclic non, cross-resistant combination of etoposide, methotrexate, and actinomycin D alternating with cyclophosphamide and vincristine.Etoposide induces complete remission in 95 of patients with nonmetastatic and low-risk metastatic GTN. The use of EMA-CO induced an 83 remission rate in patients with metastasis and a high-risk score.Ref: Berek and Novak;s Gynecology; 15th edition; Chapter 39 Gestational Trophoblastic Disease 